faslodex
astrazeneca ab - fulvestrant - bryst neoplasmer - endokrine terapi, anti-østrogener - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. i præ - eller perimenopausal kvinder, kombinationen behandling med palbociclib bør kombineres med en luteiniserende hormon releasing hormon (lhrh) agonist.
fulvestrant mylan
mylan pharmaceuticals limited - fulvestrant - bryst neoplasmer - endokrine terapi - fulvestrant er indiceret til behandling af østrogen receptor positiv, lokalt fremskreden eller metastatisk brystkræft hos postmenopausale kvinder:ikke tidligere behandlet med endokrin terapi, orwith disease, tilbagefald eller efter adjuverende anti-østrogen behandling eller af sygdomsprogression på antiøstrogen terapi.
airflusal forspiro 50+500 mikrogram inhalationspulver, afdelt
sandoz a/s - fluticasonpropionat, salmeterol - inhalationspulver, afdelt - 50+500 mikrogram
airsalb 100 mikrogram/dosis inhalationsspray, suspension
sandoz a/s - salbutamolsulfat - inhalationsspray, suspension - 100 mikrogram/dosis
dorzolamid "sandoz" 20 mg/ml øjendråber, opløsning
sandoz a/s - dorzolamidhydrochlorid - øjendråber, opløsning - 20 mg/ml
dorzolamid/timolol "sandoz" 20+5 mg/ml øjendråber, opløsning
sandoz a/s - dorzolamidhydrochlorid, timololmaleat - øjendråber, opløsning - 20+5 mg/ml
latiotim 50 mikrog/ml+5 mg/ml øjendråber, opløsning
sandoz a/s - latanoprost, timololmaleat - øjendråber, opløsning - 50 mikrog/ml+5 mg/ml
calcium-sandoz 500 mg brusetabletter
sandoz a/s - calciumcarbonat, calciumlactogluconat - brusetabletter - 500 mg
lamisil 10 mg/g gel
karo healthcare ab - terbinafin - gel - 10 mg/g
lamisil once 10 mg/g kutanopløsning
karo healthcare ab - terbinafinhydrochlorid - kutanopløsning - 10 mg/g